The NIS-Child was the first of the NIS, launched in 1994. The target population for the NIS-Child is children who are or will be 19-35 months within a few weeks of being selected to participate in the survey and living in the United States. Data are used to monitor vaccination coverage among 2-year-old children at the national, state, selected local levels, and some in U.S. territories.
The NIS-Child measures coverage of the following recommended vaccinations: Diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP/DT/DTP); Poliovirus vaccine (Polio); Measles or Measles-Mumps-Rubella vaccine (MMR); Haemophilus influenzae type b vaccine (Hib); Hepatitis B vaccine (HepB); Varicella zoster (chickenpox) vaccine (VAR); Pneumococcal conjugate vaccine (PCV); Rotavirus vaccine (ROT); Hepatitis A vaccine (HepA); Influenza vaccine (Flu).
Please note, the NIS conducts two other surveys - the National Immunization Survey-Teen (NIS-Teen)for adolescents 13-17 years; and the National Immunization Survey-Child Influenza Module (NIS-CIM) for children 6-18 months and 3-12 years who were not included in the NIS-Child or NIS-Teen.
Subscribe